BNZ-111

N/A

Report date: 2024/07/02 17:47:42
NME

Base Information

Drug NameBNZ-111
Drug Alias NameBNZ-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSamsung Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesSamsung Medical Center
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A